Heart disease is the leading cause of death globally, and 15 million people suffer stroke worldwide each year. Heart disease and stroke often result in poor quality of life and death. The adoption of healthy lifestyles can prevent heart disease. However, recent advances in systems biology have led to multiple new cardiovascular drug targets, that will challenge the unmet needs via new cardiovascular drug development.
ChemDiv presents the largest commercially available cardiovascular small molecules library for phenotypic screening. 23,000 small molecule compounds modulate the following biological targets: Adrenergic receptors, Adenosine receptors, MAP kinases, ACE, Dopamine D1 receptor, Cholesteryl ester transfer protein, and others.
Customize your library now ⬇ https://store.chemdiv.com/